Sensus Healthcare Installs First Groundbreaking SRT-100+ Superficial Radio Therapy System for Treating Keloid Scars
Dr. Kenrick Spence of Hillcrest Plastic Surgery in Orlando First to Offer System BOCA RATON, Fla., Nov. 29, 2018 — Sensus Healthcare, Inc. (NASDAQ: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers (NMSC) and keloids with Image-Guided Superficial Radio Therapy (IGSRT), has installed its first SRT-100+ system at Hillcrest […]
8th Annual “New Frontiers in Cosmetic Medicine” (NFCM) Symposium
Join Sensus Healthcare at our Superficial Radio Therapy session taking place during the upcoming New Frontiers in Cosmetic Medicine (NFCM) Symposium on Sunday, November 18th. For more information click here, or to register click here.
Sensus Healthcare Third Quarter Financial Results Feature Revenue Growth of 32%
Shipped 18 systems during the quarter including 15 SRT-100 Vision™ systems Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla., Nov. 1, 2018 — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announces financial results […]
